Crossmark

Structural classification of EGFR mutations and its association with TKI efficacy against compound and co-mutations in a Chinese NSCLC cohort: a single-center retrospective analysis

Crossref DOI link: https://doi.org/10.1186/s12885-026-16912-4

Published Online: 2026-09-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Rui

Xie, Xiaofang

Yu, Dan

Huang, Fang

Yang, Huan

Du, Hong
Funding

Funding for this research was provided by:

Suzhou Municipal Science and Technology Bureau Key Core Technology Project (SYG2024116)
License Information

Text and Data Mining valid from 2026-09-07

Accepted Manuscript valid from 2026-09-07
More Information

Article History

Received: 21 July 2026

Accepted: 31 August 2026

First Online: 7 September 2026

Declarations

Ethics approval and consent to participate: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Review Board of The Second Affiliated Hospital of Soochow University (No. JD-LK2021115-C01, Suzhou, China). All patients provided written informed consent before the study, and all patient data were anonymized.

Consent for publication: Not applicable.

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below